Prostate cancer Board decisions

The Veteran's prostate cancer was rated at 100% from June 7, 2006 to April 4, 2010. The rating was reduced to 40% effective June 1, 2008 and increased to 60% effective April 5, 2010.,The Veteran's bowel incontinence was rated at 10% prior to February 22, 2012. The rating was increased to 30% effective February 22, 2012.

The Board has denied the Veteran's claim of entitlement to service connection for prostate cancer, finding that there is no evidence of herbicide exposure during service and thus no presumption applies. The Veteran's prostate cancer was not shown in service or due to any disease or injury incurred in service.

The Veteran's claim for service connection for prostate cancer, claimed as due to exposure to ionizing radiation and/or herbicides, is being remanded for further development.

The Board has remanded the case for clarification of a VA physician assistant's opinion regarding whether the Veteran's prostate cancer is due to herbicide exposure during his service. The Veteran's claim will be reconsidered after obtaining this clarification.

The Veteran's claims for service connection are being remanded due to the need for additional development, including obtaining VA and private treatment records.

The Board has determined that the Veteran's prostate cancer is not service connected as it was not present during his military service and there is no evidence of exposure to Agent Orange. As a result, the claim for service connection for prostate cancer is denied.

The Veteran's claims for service connection for prostate cancer and erectile dysfunction due to in-service herbicide exposure or as secondary to a service-connected condition were denied because there was no evidence of herbicide exposure during active duty, and the diseases are not otherwise related to his military service.

The Veteran's prostate cancer residuals are rated at a 20 percent rating from June 1, 2007 to March 30, 2010. From March 30, 2010, the Veteran is entitled to a 40 percent disability rating for urinary frequency.

The Veteran's prostate cancer was not found to be related to his military service, including exposure to herbicide agents like Agent Orange.

The Veteran's prostate cancer was granted service connection effective March 12, 2008. The Board found that the earliest date of entitlement for this claim is February 13, 2008, when he first indicated filing a claim.

The Board denied the Veteran's claims of service connection for prostate cancer and diabetes mellitus type II, finding no evidence to support these conditions or their association with active military service.

The Veteran's prostate cancer is presumed to have been caused by his exposure to herbicides, specifically Agent Orange, during his service in Vietnam. The Board finds the Veteran's statements credible and consistent with his service records.

The Veteran's claims for increased ratings for residuals of prostate cancer and erectile dysfunction were denied as the evidence did not support a higher rating based on his symptoms. The primary issue was that he did not have deformity of the penis with loss of erectile power, which is required for a compensable rating under Diagnostic Code 7522.

The Veteran's prostate cancer was not incurred or aggravated by active military service, and the Board found no evidence of herbicide exposure in Thailand. As a result, the claim for service connection is denied.

The Veteran's prostate cancer is presumed to have been incurred during active service. The Veteran was granted an initial rating of 70 percent for his PTSD.

The Board has determined that the Veteran's prostate cancer residuals do not warrant a rating in excess of 20 percent, as there is no evidence of recurrence or metastasis and his symptoms are consistent with a 20 percent rating for urinary frequency.

The Board has determined that the Veteran's hypertension, prostate cancer, and colon cancer were not incurred in or aggravated by active service. The claim for service connection is denied.

The Board denied the Veteran's claims for service connection for diabetes mellitus, type II and residuals of prostate cancer as he did not serve in Vietnam or have any credible evidence of herbicide exposure.

The Veteran's prostate cancer residuals are rated at 20 percent since August 16, 2013. He is also entitled to a 10 percent rating for radiation proctitis and higher ratings for bilateral lower extremity peripheral neuropathy.

The Board has determined that additional development is needed to determine if the appellant was exposed to Agent Orange during his service in Vietnam, and whether he can establish service connection for his claimed conditions based on such exposure. The VA will conduct this development and then readjudicate the claims.